Phyllis Himmel Net Worth

The estimated Net Worth of Phyllis Himmel is at least 334$ dollars as of 1 August 2013. Phyllis Himmel owns over 417 units of Pro Farm Inc stock worth over 334$ and over the last 11 years Phyllis sold MBII stock worth over 0$.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Phyllis Himmel MBII stock SEC Form 4 insiders trading

Phyllis has made over 1 trades of the Pro Farm Inc stock since 2013, according to the Form 4 filled with the SEC. Most recently Phyllis bought 417 units of MBII stock worth 5,004$ on 1 August 2013.

The largest trade Phyllis's ever made was buying 417 units of Pro Farm Inc stock on 1 August 2013 worth over 5,004$. On average, Phyllis trades about 417 units every 0 days since 2013. As of 1 August 2013 Phyllis still owns at least 417 units of Pro Farm Inc stock.

You can see the complete history of Phyllis Himmel stock trades at the bottom of the page.

What's Phyllis Himmel's mailing address?

Phyllis's mailing address filed with the SEC is C/O MARRONE BIO INNOVATIONS, INC., 2121 SECOND STREET, SUITE A-107, DAVIS, CA, 95618.

Insiders trading at Pro Farm Inc

Over the last 22 years, insiders at Pro Farm Inc have traded over 9,574,054$ worth of Pro Farm Inc stock and bought 9,515,326 units worth 31,165,010$ . The most active insiders traders include Ag Science Llc Ospraie Mana...、Advisory Partnersardsley Pa...、Advisory Partners Lp Ardsle.... On average, Pro Farm Inc executives and independent directors trade stock every 49 days with the average trade being worth of 690,868$. The most recent stock trade was executed by Pamela G Marrone on 6 July 2022, trading 20,000 units of MBII stock currently worth 16,000$.

What does Pro Farm Inc do?

Marrone Bio Innovations Inc.  is a growth-oriented company leading the movement to a more sustainable world through the discovery, development and sale of innovative biological products for crop protection and plant health that help customers operate more sustainably while increasing their return on investment. MBI has screened over 18,000 microorganisms, leveraging its in-depth knowledge of plant and soil microbiomes enhanced by advanced molecular technologies and natural product chemistry to rapidly develop seven product lines. Supported by a robust portfolio of over 500 issued and pending patents, MBI's currently available commercial products are Regalia®, Stargus®, Grandevo®, Venerate®, Majestene®, Haven®, Pacesetter®, Zelto® Jet-Oxide® and Jet-Ag® , with a next-generation insecticide-nematicide, a breakthrough bioherbicide and a biofumigant in the Company's product pipeline. MBI's Pro Farm Finland-based subsidiary employs a proprietary technology derived from wood waste to stimulate plant growth and improve plant health, resulting in improved yields and crop quality. Products include UBP™ 110, Foramin®, UBP™ Seed Treatment, Foramin® ST.

Complete history of Phyllis Himmel stock trades at Pro Farm Inc

Pro Farm Inc executives and stock owners

Pro Farm Inc executives and other stock owners filed with the SEC include:

• Pamela Marrone,
  Director
• Kevin Hammill,
  Chief Commercial Officer
• Linda Moore,
  Executive Vice President, Chief Compliance Officer, General Counsel, Secretary
• Dr. Pamela G. Marrone Ph.D.,
  Founder, Advisor & Non-Employee Director
• Robert Woods,
  Independent Chairman of the Board
• Zachary Wochok,
  Independent Director
• Yogesh Mago,
  Independent Director
• Stuart Woolf,
  Independent Director
• Keith McGovern,
  Independent Director
• Greg Falesnik,
  Managing Director (MZ North America)
• Lara Lee,
  Director
• Timothy Johnson,
  Vice President - Field Development and Technical Services
• Keith Pitts,
  Senior Vice President - Regulatory and Government Affairs, Chief Sustainability Officer
• Amit Vasavada,
  Senior Vice President - Research and Development, Chief Technology Officer
• Kevin Helash,
  Chief Executive Officer, Director
• Matti Tiainen,
  Sr. VP of International Sales
• Barner Jones,
  Director of National Sales & Account Management
• Andre Trepanier,
  Director of Marketing
• Linda V. Moore,
  Chief Compliance Officer, Chief Legal Officer & Sec.
• Clyde Montevirgen,
  VP of Bus. Devel. & Investor Relations
• Dr. Amit Vasavada Ph.D.,
  Sr. VP of Research Devel. & Chief Technical Officer
• Suping Cheung CPA, Ph.D.,
  Chief Financial Officer
• Advisory Partners Lp Ardsle...,
  
• Advisory Partnersardsley Pa...,
  
• Brian R Ahrens,
  Vice President, Sales
• Richard E Rominger,
  Director
• Michael H Benoff,
  Director
• Pamela Reilly Contag,
  Director
• Advisory Partnersardsley Pa...,
  
• Timothy T Fogarty,
  Director
• Kathleen Merrigan,
  Director
• Elin D Miller,
  Director
• James Boyd,
  President and CFO
• George H Kerckhove,
  Director
• Ag Science Llc Ospraie Mana...,
  
• Advisory Partners Lp Ardsle...,
  
• & Reed Financial Incwaddell...,
  
• Hector Absi,
  See Remarks
• Leslie F Lyman,
  Director
• Donald J Glidewell,
  CFO and Secretary
• Joseph Hudson,
  Director
• Ranjeet Bhatia,
  Director
• Lawrence A Hough,
  Director
• Phyllis Himmel,
  V.P. of Biological Research
• Alison Stewart,
  SR VP of R&D and CTO
• Ventures Pte. Ltd. Syngenta,
  10% owner
• Shaugn Stanley,
  Director
• Mill Venture Partners Lp St...,
  
• Ag Science Llc Anderson Dwi...,
  
• Advisory Partners Lpardsley...,
  
• Matti Tiainen,
  SVP, International Sales
• Ag Science Llc Ospraie Mana...,
  
• Suping (Sue) Cheung,
  Chief Financial Officer